Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sajitha Sachchithanantham

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
British Medical Bulletin|July 31, 2013
Imaging in systemic amyloidosisSajitha Sachchithanantham, Ashutosh D Wechalekar
British Journal of Haematology|October 31, 2017
Role of <sup>99m</sup> Tc-DPD scintigraphy in imaging extra-cardiac light chain (AL) amyloidosisSajitha Sachchithanantham, David F Hutt, Ann-Marie Quigley, et al.
British Journal of Haematology|May 17, 2023
Is there a representative quality-of-life questionnaire for patients with AL amyloidosis?-systematic literature reviewSotirios Bristogiannis, Jahanzaib Khwaja, Yadanar Lwin, et al.
British Journal of Haematology|August 11, 2018
Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosisFaye A Sharpley, Richa Manwani, Shameem Mahmood, et al.
Blood|May 20, 2015
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosisGiovanni Palladini, Sajitha Sachchithanantham, Paolo Milani, et al.
British Journal of Haematology|October 10, 2017
Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosisSajitha Sachchithanantham, Oscar Berlanga, Azra Alvi, et al.
European Journal of Haematology|January 9, 2013
Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myelomaSally Moore, Sangeeta Atwal, Sajitha Sachchithanantham, et al.
Blood Cancer Journal|February 6, 2019
A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosisFaye A Sharpley, Richa Manwani, Shameem Mahmood, et al.
British Journal of Haematology|June 19, 2013
Clinical profile and treatment outcomes of immunoglobulin D associated AL amyloidosisMurielle Roussel, Sajitha Sachchithanantham, Simon D J Gibbs, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 26, 2020
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patientsPaolo Milani, Faye Sharpley, Stefan O Schönland, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
British Medical Bulletin|July 31, 2013
Imaging in systemic amyloidosisSajitha Sachchithanantham, Ashutosh D Wechalekar
British Journal of Haematology|October 31, 2017
Role of <sup>99m</sup> Tc-DPD scintigraphy in imaging extra-cardiac light chain (AL) amyloidosisSajitha Sachchithanantham, David F Hutt, Ann-Marie Quigley, et al.
British Journal of Haematology|May 17, 2023
Is there a representative quality-of-life questionnaire for patients with AL amyloidosis?-systematic literature reviewSotirios Bristogiannis, Jahanzaib Khwaja, Yadanar Lwin, et al.
British Journal of Haematology|August 11, 2018
Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosisFaye A Sharpley, Richa Manwani, Shameem Mahmood, et al.
Blood|May 20, 2015
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosisGiovanni Palladini, Sajitha Sachchithanantham, Paolo Milani, et al.
British Journal of Haematology|October 10, 2017
Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosisSajitha Sachchithanantham, Oscar Berlanga, Azra Alvi, et al.
European Journal of Haematology|January 9, 2013
Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myelomaSally Moore, Sangeeta Atwal, Sajitha Sachchithanantham, et al.
Blood Cancer Journal|February 6, 2019
A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosisFaye A Sharpley, Richa Manwani, Shameem Mahmood, et al.
British Journal of Haematology|June 19, 2013
Clinical profile and treatment outcomes of immunoglobulin D associated AL amyloidosisMurielle Roussel, Sajitha Sachchithanantham, Simon D J Gibbs, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 26, 2020
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patientsPaolo Milani, Faye Sharpley, Stefan O Schönland, et al.
Pageof 6